embecta to Participate at the J.P. Morgan 2026 Healthcare Conference
Embecta (Nasdaq: EMBC) said management will present at the J.P.
Rhea-AI Summary
Embecta (Nasdaq: EMBC) said management will present at the J.P. Morgan 2026 Healthcare Conference in San Francisco on Wednesday, January 14, 2026 at 2:15 p.m. PT / 5:15 p.m. ET. Audio webcasts of the presentations will be available in the News & Events section of the company's investor relations website at investors.embecta.com.
Details
News Market Reaction – EMBC
On Dec 19, the first trading day after this news, EMBC closed 0.34% above the previous close.
Data tracked by StockTitan Argus for the Dec 19 session.
Key Figures
- Conference date
- January 14, 2026
- J.P. Morgan Healthcare Conference presentation date
- Presentation time PT
- 2:15 p.m. PT
- Scheduled conference presentation time
- Presentation time ET
- 5:15 p.m. ET
- Scheduled conference presentation time
Historical Context
-
FY2025 results and FY2026 guidance with revenue declines versus prior year.
-
Quarterly cash dividend of $0.15 per share announced.
-
Director resignation and planned leadership transitions on the board.
-
Expanded Direct Relief partnership and donations of diabetes injection devices.
-
Announcement of timing for FY2025 results and guidance call.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PARSIPPANY, N.J., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 14, 2026 at 2:15 p.m. PT / 5:15 p.m. ET.
Audio webcasts of the presentations will be accessible under the “News & Events” section of the Company's investor relations website at investors.embecta.com.
About embecta
embecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, helping to improve lives through innovative solutions, partnerships, and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram.
Contacts:
| Media Christian Glazar Sr. Director, Corporate Communications 908-821-6922 Contact Media Relations | Investors Pravesh Khandelwal VP, Head of Investor Relations 551-264-6547 Contact IR |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.